MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing ichthyosis, enabling early detection and personalized treatment, and its impact on family planning and dermatology advancements.
Unlock idiopathic bronchiectasis's mysteries with genetic testing, leading to precise diagnoses, personalized treatments, and informed family planning options.
Meta Description: Navigate Immunodeficiency 14b with genetic testing insights on early diagnosis, personalized treatment, and family planning for effective disease management.
Discover the role of the SLCO2A1 gene in inherited isolated nail anomaly. Learn how genetic testing aids in early diagnosis, family planning, and personalized treatment.
Explore the role of genetic testing in managing inherited obesity. Learn how personalized plans and preventive measures can address genetic predispositions effectively.
Explore how genetic testing enhances the diagnosis and management of inherited susceptibility to mycobacterial diseases, offering personalized care and early detection.
Explore how genetic testing uncovers the exon 3 deletion in ryanodine receptor, aiding early LVNC diagnosis, family risk assessment, and personalized treatments.
Genetic testing advances improve leukodystrophy diagnosis, enabling personalized treatment and early intervention, crucial for better management of this complex disorder.